Maryam Safari

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Intellectual Disability

Signaling Pathway

Histone Deacetylase

Top Venues

Molecular cancer research : MCR

Molecular cancer therapeutics

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Maryam Safari, Luigi Scotto, Agnes Basseville, Thomas Litman, Haoran Xue, Luba Petrukhin, Ping Zhou, Diana V Morales, Christopher Damoci, Mingzhao Zhu, Kenneth Hull, Kenneth P Olive, Tito Fojo, Daniel Romo, Susan E Bates
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma. bioRxiv : the preprint server for biology (2024)
Maryam Safari, Luigi Scotto, Thomas Litman, Lubov A Petrukhin, Hu Zhu, Min Shen, Robert W Robey, Matthew D Hall, Tito Fojo, Susan E Bates
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms. Cancers 15 (20) (2023)
Agnes Basseville, Pierre-Christian Violet, Maryam Safari, Carole Sourbier, W Marston Linehan, Robert W Robey, Mark Levine, Dan L Sackett, Susan E Bates
A Histone Deacetylase Inhibitor Induces Acetyl-CoA Depletion Leading to Lethal Metabolic Stress in RAS-Pathway Activated Cells. Cancers 14 (11) (2022)
Maryam Safari, Thomas Litman, Robert W Robey, Andrés Aguilera, Arup R Chakraborty, William C Reinhold, Agnes Basseville, Lubov Petrukhin, Luigi Scotto, Owen A O'Connor, Yves Pommier, Antonio T Fojo, Susan E Bates
R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin. Molecular cancer research : MCR 19 (8) (2021)
Luigi Scotto, Cristina Kinahan, Eugene Douglass, Changchun Deng, Maryam Safari, Beatrice Casadei, Enrica Marchi, Jennifer Kimberly Lue, Francesca Montanari, Lorenzo Falchi, Changhong Qiao, Nandakumar Renu, Susan E Bates, Andrea Califano, Owen A O'Connor
Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways. Molecular cancer therapeutics 20 (8) (2021)